Understanding Blood Plasma and Its Role in Medical Diagnostics

Blood plasma is the liquid component of blood that circulates throughout the body, serving as a vital repository for thousands of proteins derived from every organ and tissue [1]. Because it contains this complex "plasma proteome," scientists increasingly view plasma sampling as a form of liquid biopsy that provides a real-time snapshot of a person's health and disease status [1].

Key takeaways

• Blood plasma contains thousands of proteins that reflect the health of various organs and tissues [1].
• Emerging research suggests that specific protein signatures in plasma can act as early predictors for conditions like lung cancer [1].
• Optical techniques, such as Brillouin light scattering spectroscopy, are being studied to measure plasma viscosity to assess the severity of diseases like COVID-19 [2].
• Regular plasma donations may help reduce the levels of "forever chemicals," or PFAS, that accumulate in the human body [3].

Diagnostic potential of the plasma proteome

The systematic study of the plasma proteome, known as proteomics, allows researchers to identify significant clues about how a person transitions from health to illness [1]. For example, a multinational research team recently identified a "14-protein signature" in blood plasma that can predict a lung cancer diagnosis years in advance [1]. By training machine-learning models on proteomics data from large volunteer groups, such as those in the U.K. Biobank, scientists have successfully identified these markers with high sensitivity [1].

Beyond protein analysis, the physical properties of plasma are also being investigated for diagnostic utility. Researchers at MedUni Vienna have utilized Brillouin light scattering spectroscopy to measure the viscosity of plasma [2]. This optical method can analyze small quantities of plasma in less than a second, revealing significant differences in viscosity and temperature dependence in patients with COVID-19 [2]. These physical changes in plasma may explain complications like multi-organ failure by affecting blood flow in the smallest vessels [2].

Health implications and future research

The contents of blood plasma are not only indicators of internal disease but can also be influenced by external environmental factors. Research published in JAMA Network Open indicates that regular plasma donations can significantly reduce the levels of per- and polyfluoroalkyl substances (PFAS) in the body [3]. These "forever chemicals," which accumulate in blood and tissue from exposure to household items and environmental sources, are linked to immune system impairment and increased risks of thyroid disorders, liver disease, and cancer [3].

Why it matters

The ability to analyze blood plasma provides a non-invasive, efficient way to monitor human health and potentially intervene before diseases become life-threatening. While the 14-protein signature for lung cancer shows promise, it requires further validation across diverse populations and the development of standardized diagnostic tests [1]. Similarly, while optical viscosity measurements and the reduction of PFAS through donation offer new clinical possibilities, further research is required to optimize these methods for widespread medical use [2, 3]. As scientists continue to refine these techniques, plasma remains a critical frontier in the development of proactive diagnostics and targeted therapeutic strategies [1, 2].